Shintaro Saito 研究室

AI 要約（直近 5 年の研究成果）

※ AI（Claude）が、公開されている論文要旨から研究の問い・手法・主要な発見を事実情報として抽出・再構成して自動生成しています。誤りを含む可能性があるため、正確性は研究室公式情報でご確認ください。

研究成果（20 件）

• [2026] Favorable Outcome of Umbilical Melanoma With Bilateral Inguinal Lymph Node Metastases Treated With Lymph Node Dissection and Adjuvant Nivolumab: A 37‐Month Recurrence‐Free Case
  DOI: https://doi.org/10.1111/1346-8138.70308
• [2026] Protective effects of the selective JAK2/3 inhibitor AG490 against ulcer formation following cutaneous ischemia-reperfusion injury
  DOI: https://doi.org/10.1016/j.jdermsci.2026.03.004
• [2026] Colorectal Cancer Developing From Residual Colorectal Mucosa at a Previous Temporary Colostomy Site: A Case Report and Literature Review
  DOI: https://doi.org/10.1111/1346-8138.70143
• [2025] Effectiveness and Prognosis of Systemic Chemotherapy for Unresectable Malignant Apocrine and Eccrine Tumors: A Real-World Multicenter Retrospective Study
  DOI: https://doi.org/10.1200/go-25-00180
• [2025] An Autopsy Case of Neurofibromatosis Type 1 Mutation Detected in a Duodenal Lesion of Malignant Melanoma: A Case Report
  DOI: https://doi.org/10.7759/cureus.90933
• [2023] Efficacy of salvage therapies for advanced acral melanoma after anti-PD-1 monotherapy failure: a multicenter retrospective study of 108 Japanese patients
  DOI: https://doi.org/10.3389/fmed.2023.1229937
• [2023] Evaluation of prognostic prediction ability of the novel Japanese risk factor scoring system in a Japanese cohort of resectable cutaneous squamous cell carcinoma: A retrospective cross‐sectional study
  DOI: https://doi.org/10.1111/exd.14873
• [2022] Efficacy Comparison between Anti-PD-1 Antibody Monotherapy and Anti-PD-1 Plus Anti-CTLA-4 Combination Therapy as First-Line Immunotherapy for Advanced Acral Melanoma: A Retrospective, Multicenter Study of 254 Japanese Patients
  DOI: https://doi.org/10.2139/ssrn.4090733
• [2022] Comparison of surgical morbidities between <scp>LigaSure™</scp> and conventional techniques in inguinal or ilioinguinal lymph node dissection for skin cancer: A single center retrospective study
  DOI: https://doi.org/10.1111/1346-8138.16502
• [2022] Efficacy comparison between anti-PD-1 antibody monotherapy and anti-PD-1 plus anti-CTLA-4 combination therapy as first-line immunotherapy for advanced acral melanoma: A retrospective, multicenter study of 254 Japanese patients
  DOI: https://doi.org/10.1016/j.ejca.2022.08.030

科研費（0 件）

まだデータがありません（KAKEN 取り込み後に表示）。

所属学会・役職（0 件）

まだデータがありません（学会データ連携後に表示）。